论文部分内容阅读
在跨界医疗的险资大军中,泰康保险集团股份有限公司(以下简称“泰康集团”)近年来动作频频。近日,泰康保人寿和复星医药共同出资,用于重组徐州矿务集团有限公司(以下简称“徐矿集团”)所属医疗机构的10亿元股权资金到位,这标志着三方合作成立的淮海医院管理集团进入实质性运营阶段。事实上,投资徐矿集团所属医疗机构并非泰康保险首次“触医”。资料显示,2015年9月泰康以50亿元获仙林鼓楼医院80%股权,这是中国险企拥有
In the cross-border medical insurance army, Taikang Insurance Group Co., Ltd. (hereinafter referred to as “Taikang Group”) in recent years, frequent moves. Recently, Taikang Life Insurance and Fosun Pharma co-financed the funding of 1 billion yuan for restructuring the medical institutions affiliated to Xuzhou Mining Group Co., Ltd. (hereinafter referred to as “Xu Mining Group”), which marked the establishment of the tripartite cooperation Huaihai Hospital Management Group entered a substantive operational phase. In fact, it is not the first time for Taikang Insurance to invest in the medical institutions affiliated to Xu Mining Group. Data show that in September 2015 Taikang 50 billion won 80% stake in Xian Drum Tower Hospital, which is owned by China insurance companies